Logo Image
|Articles|May 11, 2006

Regent Medical Merges With Molnlycke

NORCROSS, Ga. -- Regent Medical Americas, the North American arm of Regent Medical Ltd., announces completion of Regent Medical Ltds merger with Mölnlycke Health Care and Medlock Medical, creating a leading medical products group, Mölnlycke Health Care Group, with a strong brand focus. 

According to Lundy Fields, formerly Regent Medical Americas president and now Mölnlycke Health Care U.S. president, the merger of Gothenburg, Sweden-based Mölnlycke Health Care with two Manchester, United Kingdom-based companies (Regent Medical and Medlock Medical), results in a new force in global healthcare. The compelling strategic fit between Mölnlycke and Regent, a leading surgical supplier known for its two brands Biogel® powder-free surgical gloves and HIBICLENS® antiseptic/antimicrobial skin cleanser, and Medlock, a niche wound care company, creates a company with a significantly enhanced product range and opportunity in the market, Fields said.

The companys two strategic divisions will be Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division will encompass a leading manufacturer and supplier of powder-free surgical gloves (Biogel® surgical gloves) and a leading supplier of skin cleanser (Hibiclens® and Hibistat® antiseptics). A leader in trauma and pain management, the Wound Care Divisions market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment. 

There are clear synergies between the companies in terms of sales force and distribution as well as in R&D; this, together with a more decentralized approach by management, will see the opportunities for cost savings, increased profitability and an accelerated top line growth.

Commenting on the new strategy, Mölnlycke CEO John Samuel said, The platform for future growth is in place and now it is time for us to focus on improving and expanding our business. Our strategy is two-fold: In Surgical, we plan to take advantage of the growing market need for single use products and further expand geographically; and in Wound Care, we plan to grow the advanced wound care business from the strong base of the market leading Safetac® technology both with innovative new products and further geographical spread.

Related to this article

View more
Image of Pathogens flying (Adobe Stock weerasak)
How 3 Decades of SHEA Presidents Shaped the Science and Soul of Infection Prevention
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
Read more
A brightly lit Hospital operating room, a surgical team wearing gowns and masks. (Adobe Stock 1790696595 by Damian)
How Can OR Teams Improve Environmental Cleaning Between Surgical Cases?
Turnover pressure can leave critical OR cleaning steps unfinished. Karen deKay, MSN, RN, EBP-C, CNOR, CIC, FAPIC, examines common gaps in environmental hygiene and how shared responsibilities, attention to disinfectant contact time, and ongoing education can help teams strengthen practices between cases.
Read more
A group of students raising their hands in class during a lecture (Adobe Stock 292282454 by Mediteraneo
Once a Teacher, Always a Teacher: Why Infection Prevention Is Education
How do you celebrate an infection that never happened? That's one of the unusual challenges infection preventionists share with teachers. Both can spend their careers changing outcomes they may never see. Both educate people who don't always want to listen. Both are second-guessed. Both face burnout. And both must somehow keep remembering why they started.
Read more
Water (Adobe Stock 456102510 by stockphoto-graf)
Where to Begin With ST108: Water Testing and Implementation Readiness
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Read more
AORN26 New Orleans 2026 (Adobe Stock)
How Can OR and Sterile Processing Teams Improve Collaboration and Instrument Readiness?
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.
Read more